Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by mcnabbpaon Apr 25, 2013 9:48am
133 Views
Post# 21299553

RE: RE: RE: RE: RE: bad news

RE: RE: RE: RE: RE: bad news

 That's the way I see it as well Ster123. Our new resident basher brough up EKG and their spike and resulting consolidation in a bear market, what he neglected to mention is the fact that when EKG came out with their FDA approval nr, not many people bothered to check when the ekg pen was hitting the market.......the day after the nr, the company told me it would be 6 months to a year before they were commercially available.....it's no wonder the price retraced.

 In VPT's case we already have units in place, units manufactured and U.S. customers from the clinical studies who are DYING to get FDA approval for clinical use of the units........cardiologist LOVE these things!

MC ( disclaimer: any mention of payment to fellow posters of scotch, for bet on FDA approval before April 30, are declared null and void upon notice of delays.......plus I had my fingers crossed.

Bullboard Posts